POSA126 An Economic Analysis of Empagliflozin Versus Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (HFREF) in the United Kingdom (UK)
Abstract
Authors
O Reifsnider A Tafazzoli L Bellanca M Litkiewicz M Stargardter S Linden